UnicoCell Biomed Co., Ltd. UnicoCell Biomed Co., Ltd.

UnicoCell Biomed Co., Ltd.

6794

Rank in Stocks #18636
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the... UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
Share Price
$2.02
Last synced: 2026-11-19
Market Cap
$122.74M
Change (1 day)
-5.20%
Change (1 year)
-10.83%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade UnicoCell Biomed Co., Ltd. (6794)

Category

Healthcare
Operating Margin for UnicoCell Biomed Co., Ltd. (6794)
Operating Margin as of November 2026 TTM: -432.77%
According to UnicoCell Biomed Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -432.77%. At the end of 2025 the company had an operating margin of -432.77%.
Operating Margin history for UnicoCell Biomed Co., Ltd. from 2017 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -432.77% 0.00%
2025 -432.77% 34.06%
2024 -322.82% -17.56%
2023 -391.56% -38.80%
2022 -639.78% -40.10%
2021 -1,068.08% -60.72%
2020 -2,718.86% 323.45%
2019 -642.07% -48.90%
2018 -1,256.52% 69.99%
2017 -739.17% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -99.55%
US
33.87% -100.08%
US
-116.04% -99.73%
US
25.57% -100.06%
AU
31.23% -100.07%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about UnicoCell Biomed Co., Ltd.'s operating margin

What is UnicoCell Biomed Co., Ltd.'s operating margin?

UnicoCell Biomed Co., Ltd.'s operating margin is -432.77%, as of Nov 2026.

What was UnicoCell Biomed Co., Ltd.'s operating margin in 2025?

In 2025, UnicoCell Biomed Co., Ltd.'s operating margin was -432.77%, compared with -322.82% in 2024.

How has UnicoCell Biomed Co., Ltd.'s operating margin changed since 2020?

From 2020 to 2025, UnicoCell Biomed Co., Ltd.'s operating margin was highest in 2024 (-322.82%) and lowest in 2020 (-2,718.86%).

How does UnicoCell Biomed Co., Ltd.'s operating margin compare with similar companies?

UnicoCell Biomed Co., Ltd.'s operating margin (-432.77%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.